Omid A. Hamid, MD | Authors

Articles

Options for Patients With Melanoma Who Have Exhausted Standard Therapies

February 20, 2018

Omid A. Hamid, MD, chief of Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses options for patients with melanoma who have exhausted standard therapies.